Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
33.75
+0.17 (0.51%)
At close: Aug 22, 2025, 4:00 PM
33.08
-0.67 (-1.99%)
After-hours: Aug 22, 2025, 7:05 PM EDT
KNSA Market Cap
KNSA has a market cap or net worth of $2.50 billion as of August 22, 2025. Its market cap has increased by 46.22% in one year.
Market Cap
2.50B
Enterprise Value
2.20B
1-Year Change
46.22%
Ranking
Category
Stock Price
$33.75
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $2.50B, an increase of 165.19%. That is a compound annual growth rate of 14.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 2.50B | 75.13% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |